10:25am ET
Health and Healthcare
Pfizer’s Chantix Study Goes Up in Smoke
Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.
Chris Lange
Companies
/Healthcare
Pfizer Inc
$27.96
▼ $0.06 (−0.21%) today
Markets closed · 2:35pm ET
PFE Coverage
Page 41 Chris Lange 8:35am ET
Health and Healthcare
Major Pharma Sees Big Drop in Short Interest
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
7:00am ET
Investing
GE and Intel Remain Short Sellers’ Favorite Dow Stocks
As of the most recently reported period, short sellers still favored just two Dow stocks, General Electric and Intel, above all others.
4:07pm ET
Investing
The Dow Propped Up by Johnson & Johnson, Pfizer Thursday
The Dow wobbled around Thursday and looks set to close very near the break-even line as J&J, Pfizer, Caterpillar, and McDonald's pushed higher.
9:10am ET
Health and Healthcare
Short Sellers Hike Bets in Major Pharma
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
2:52pm ET
Health and Healthcare
Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?
If the collaboration between Sangamo and Kite Pharma works out, some investors might just ask why Gilead did not just acquire Sangamo.
4:01pm ET
Investing
Pfizer, UnitedHealth Boost DJIA on Friday
Pfizer, UnitedHealth, Disney, and Johnson & Johnson lifted the DJIA on Friday.
9:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Pharma
The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:15am ET
Health and Healthcare
JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps
Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety and income.
1:55pm ET
Investing
10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News
These are the 10 stocks tracked by 24/7 Wall St. that received multiple analyst rating upgrades or price target hikes of Wednesday, January 31, 2018.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot Locker, McDonald's and Pfizer.
4:01pm ET
Investing
UnitedHealth, Pfizer Tank the DJIA Tuesday
UnitedHealth, Pfizer, McDonald's, and General Electric put in a dismal day and led the DJIA to steep loss Tuesday.
7:55am ET
Health and Healthcare
Pfizer Earnings, Guidance May Not Be Enough for Investors
Pharmaceuticals giant Pfizer beat quarterly and full-year expectations this morning, but the beats were small and the forecast for next year is not exhilarating.
Paul Ausick 10:20am ET
Investing
Apple, Boeing, Microsoft and More Dow Earnings Coming This Week
24/7 Wall St. has put together a preview of Exxon, Apple, Pfizer and other the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
4:01pm ET
Investing
Intel, Pfizer Drive DJIA Surge Higher on Friday
Intel, Pfizer, 3M, and Disney launched the DJIA to a solid gain Friday.